Piper Sandler & Co. Alx Oncology Holdings Inc Transaction History
Piper Sandler & Co.
- $80,000
- Q4 2024
Shares
2 transactions
Others Institutions Holding ALXO
# of Institutions
96Shares Held
39.5MCall Options Held
213KPut Options Held
44.8K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$6.89 Million13.33% of portfolio
-
Redmile Group, LLC San Francisco, CA3.69MShares$2.62 Million0.48% of portfolio
-
Tang Capital Management LLC San Diego, CA3.3MShares$2.34 Million0.41% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$1.91 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.5MShares$1.77 Million0.0% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $28.9M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...